Table V.
Sensitivity analyses using different measures of pulmonary disease
| Comorbidities∗ | Adjusted odds of hospitalization |
||
|---|---|---|---|
| Model A (n/N = 284/1877) | Model B (n/N = 284/1877) | Model C (n/N = 284/1877) | |
| SCD | 7.0 (3.0-16.3) | 6.8 (2.9-15.5) | 6.5 (2.8-15.1) |
| Immunocompromising condition | 6.7 (3.9-11.4) | 6.4 (3.8-10.9) | 6.1 (3.6-10.5) |
| Obesity | 3.2 (2.1-4.9) | 3.3 (2.2-5.0) | 3.3 (2.2-5.0) |
| CKD | 3.1 (0.9-11.5) | 3.1 (0.9-11.2) | 3.0 (0.8-10.8) |
| Diabetes | 3.1 (1.5-6.5) | 3.1 (1.5-6.5) | 2.7 (1.3-5.8) |
| Neurologic disease | 2.8 (1.8-4.4) | 2.9 (1.9-4.5) | 2.7 (1.7-4.3) |
| Pulmonary disease | |||
| Model A: any preexisting pulmonary disease | 1.7 (1.3-2.4) | --- | --- |
| Model B: asthma on inhaled corticosteroids | --- | 1.2 (0.6-2.3) | --- |
| Model C: preexisting pulmonary disease, excluding asthma | --- | --- | 3.4 (1.6-6.9) |
| Heart disease | 1.5 (0.8-3.1) | 1.7 (0.8-3.4) | 1.5 (0.7-3.0) |
All sensitivity models are adjusted for race/ethnicity.
∗
For each comorbidity variable, the reference is absence of that comorbidity.